| CTRI Number |
CTRI/2025/03/082812 [Registered on: 19/03/2025] Trial Registered Prospectively |
| Last Modified On: |
19/12/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparing the Effects of Two Medicines, Esmolol and Labetalol, on Heart rate and Blood Pressure Control During Breathing Tube Removal After Surgery |
|
Scientific Title of Study
|
A randomised study to compare the effects of i.v Esmolol vs i.v Labetalol in attenuating hemodynamic response during extubation in Department of Anesthesia, S.M.S Medical College Jaipur |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Shriphal Meena |
| Designation |
Senior Professor |
| Affiliation |
Sawai Man Singh Medical College and Hospital, Jaipur |
| Address |
Department of Anaesthesia , SMS Medical college, Jaipur, Rajasthan
Jaipur RAJASTHAN 302004 India |
| Phone |
9928350391 |
| Fax |
|
| Email |
dr.shriphal@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Shriphal Meena |
| Designation |
Senior Professor |
| Affiliation |
Sawai Man Singh Medical College and Hospital, Jaipur |
| Address |
Department of Anaesthesia , SMS Medical college, Jaipur, Rajasthan
Jaipur RAJASTHAN 302004 India |
| Phone |
9928350391 |
| Fax |
|
| Email |
dr.shriphal@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Snehal Dudekula |
| Designation |
Junior Resident |
| Affiliation |
Sawai Man Singh Medical College and Hospital, Jaipur |
| Address |
Department of Anaesthesia , SMS Medical college, Jaipur, Rajasthan
Jaipur RAJASTHAN 302004 India |
| Phone |
8978419820 |
| Fax |
|
| Email |
snehaldudekula3@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Anaesthesiology, second floor, Dhanvantri complex, SMS medical college and hospitals, Jaipur, India, 302004 |
|
|
Primary Sponsor
|
| Name |
Sawai man singh medical college |
| Address |
Department of Anaesthesia,second floor,Dhanwantri OPD Block, SMS medical college, Jaipur, India,302004 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Shriphal Meena |
SMS medical college and Hospitals |
Department of Anaesthesiology and critical care, Second floor , Dhanwantri opd block, SMS medical college, Jaipur. Jaipur RAJASTHAN |
9928350391
dr.shriphal@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Office of the Ethics Committee, SMS medical college and Hospitals |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
, (1) ICD-10 Condition: K400||Bilateral inguinal hernia, with obstruction, without gangrene, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Inj. Esmolol |
1.5mg/kg Intravenous drug is given once, 2mins before extubation and observed over a period of 10 mins |
| Comparator Agent |
Inj. Labetalol |
0.25mg/kg Intravenous drug is given once, 2mins before extubation and observed over a period of 10 mins. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
1.Patients giving consent for general anaesthesia
2.Adult patients of either sex
|
|
| ExclusionCriteria |
| Details |
1.Patients posted for emergency surgery
2.Physical status ASA Class III or more
3.Patients having any significant systemic disorder
4.Patients having comorbid diseases
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Heart rate |
baseline, after giving reversal, at the end of drug administration, 1 min after administration, at the time of extubation, after extubation |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| systolic bp, diastolic bp, mean arterial bp |
baseline, after giving reversal, at the end of drug administration, 1 min after administration, at the time of extubation, after extubation |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
22/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Background: During extubation, the process of removing a breathing tube after surgery, patients often experience significant hemodynamic responses such as increased heart rate and blood pressure due to airway stimulation. These responses can cause complications, especially in patients with cardiovascular risks. Beta-blockers like esmolol and labetalol are commonly used to manage these responses due to their cardio-protective properties. However, there is limited evidence comparing their effectiveness and safety during extubation. Purpose: The study aims to compare the efficacy of intravenous esmolol and labetalol in attenuating the hemodynamic responses during extubation. The goal is to determine which drug provides better control of heart rate and blood pressure with minimal side effects, ensuring a safer extubation process for patients undergoing general anesthesia. |